Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a new drug candidate for the treatment of patients with mild-to-moderate psoriasis. Their dietary supplements are sold globally both as bulk ingredients and as finished products under the ROMEGA brand, to both corporate and private customers.